{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:59:31Z","timestamp":1789822771257,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.mjafi.2014.02.001","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T01:30:35Z","timestamp":1395711035000},"page":"71-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Denosumab: A bone antiresorptive drug"],"prefix":"10.1016","volume":"71","author":[{"given":"Navdeep","family":"Dahiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjan","family":"Khadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishith","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.B.S.","family":"Brashier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mjafi.2014.02.001_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1759720X11424220","article-title":"A review of the efficacy and safety of denosumab in postmenopausal women with osteoporosis: a review","volume":"3","author":"Paul","year":"2011","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"9773","key":"10.1016\/j.mjafi.2014.02.001_bib2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"New horizons in osteoporosis","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.mjafi.2014.02.001_bib3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.mjafi.2014.02.001_bib4","unstructured":"FDA Approval for Denosumab. [Cited 2013 June 13]. Available from: http:\/\/www.fda.gov\/informationOnDrugs\/ApprovedDrugs\/ucm356667.htm."},{"key":"10.1016\/j.mjafi.2014.02.001_bib5","first-page":"295","article-title":"Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab","volume":"8","author":"Athanasios","year":"2012","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.mjafi.2014.02.001_bib6","first-page":"1","article-title":"Comparison of the effect of denosumab and alendronate on bone Mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial","author":"Brown","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.mjafi.2014.02.001_bib7","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1359\/jbmr.070809","article-title":"Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD","volume":"22","author":"Lewiecki","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.mjafi.2014.02.001_bib8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.mjafi.2014.02.001_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/OTT.S30578","article-title":"Denosumab: a new option in the treatment of bone metastases from urological cancers","volume":"5","author":"Yuasa","year":"2012","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.mjafi.2014.02.001_bib10","doi-asserted-by":"crossref","first-page":"w13624","DOI":"10.4414\/smw.2012.13624","article-title":"The future of osteoporosis treatment \u2013 a research update","volume":"142","author":"Lippuner","year":"2012","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"10.1016\/j.mjafi.2014.02.001_bib11","first-page":"S51","article-title":"Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: result of a randomized phase II trial","volume":"189","author":"Karim","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.mjafi.2014.02.001_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00198-012-2052-4","article-title":"Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial","volume":"24","author":"McClung","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.mjafi.2014.02.001_bib13","unstructured":"A Six Month Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study With A Six Month Open-label Extension To Evaluate The Efficacy And Safety Of Denosumab In Korean Postmenopausal Women With Osteoporosis. [Cited on 2013 Dec 8]. Available from: http:\/\/www.gsk clinicalstudyregister.com\/study\/114163#rs."},{"key":"10.1016\/j.mjafi.2014.02.001_bib14","unstructured":"A Six-month Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study To Evaluate The Efficacy And Safety Of Denosumab In Indian Postmenopausal Women With Osteoporosis. [Cited on 2013 Dec 8]. Available from: http:\/\/www.gsk-clinicalstudyregister.com\/study\/114161#ps."},{"key":"10.1016\/j.mjafi.2014.02.001_bib15","unstructured":"A Study Comparing Denosumab With Zoledronic Acid In Subjects Of Asian Ancestry With Bone Metastasis From Solid Tumours. [Cited on 2013 Dec 8]. Available from: http:\/\/www.gsk-clinicalstudyregister.com\/study\/114273#ps."},{"issue":"3","key":"10.1016\/j.mjafi.2014.02.001_bib16","first-page":"593","article-title":"Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts","volume":"22","author":"Lange","year":"2013","journal-title":"Eur Spine J"},{"key":"10.1016\/j.mjafi.2014.02.001_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1148\/rg.331125089","article-title":"Giant cell tumor of bone: review, mimics, and new developments in treatment. Musculoskeletal imaging","volume":"33","author":"Chakarun","year":"2013","journal-title":"Radiographics"},{"key":"10.1016\/j.mjafi.2014.02.001_bib18","series-title":"Harrison\u2019s Principles of Internal Medicine: Osteoporosis","first-page":"3131","author":"Lindsay","year":"2012"},{"key":"10.1016\/j.mjafi.2014.02.001_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1345\/aph.1E357","article-title":"Discovery, clinical development and therapeutic uses of bisphosphonates","volume":"39","author":"Licata","year":"2005","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.mjafi.2014.02.001_bib20","unstructured":"File no.6\u20138\/FF-08\/2012-BD(Biotech). Form 41. Registration certificate no.FFR-27. Dtd 28 Feb 2013. Available from: [Cited on 2013 Dec 28]. http:\/\/www.cdsco.nic.in\/biological09.07...\/recombinant%20RC%202013.pdf."},{"issue":"1","key":"10.1016\/j.mjafi.2014.02.001_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/erp.12.76","article-title":"Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women","volume":"13","author":"Hiligsmann","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123714000264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123714000264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:43:00Z","timestamp":1759837380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123714000264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0377123714000264"],"URL":"https:\/\/doi.org\/10.1016\/j.mjafi.2014.02.001","relation":{},"ISSN":["0377-1237"],"issn-type":[{"value":"0377-1237","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Denosumab: A bone antiresorptive drug","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mjafi.2014.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}